News about "radical surgical resection"

Daiichi Sankyo and AstraZeneca Dose First Patient in Phase 3 Trial of Datroway for Muscle-Invasive Urothelial Cancer

Daiichi Sankyo and AstraZeneca Dose First Patient in Phase 3 Trial of Datroway for Muscle-Invasive Urothelial Cancer

The first patient has been dosed in the global Phase 3 TROPION-Urothelial04 trial, advancing evaluation of Datroway-based therapies for high-risk muscle-invasive urothelial cancer.

Radical Surgical Resection | 27/08/2026 | By News Bureau


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members